Vasundhara Rasayans Limited (BOM:538634)
120.00
-4.40 (-3.54%)
At close: Mar 6, 2026
Vasundhara Rasayans Market Cap
Vasundhara Rasayans has a market cap or net worth of 381.38 million as of March 6, 2026. Its market cap has decreased by -55.83% in one year.
Market Cap
381.38M
Enterprise Value
380.06M
Revenue
315.86M
Ranking
n/a
PE Ratio
10.26
Stock Price
120.00
Market Cap Chart
Since January 13, 2015, Vasundhara Rasayans's market cap has increased from 41.32M to 381.38M, an increase of 823.08%. That is a compound annual growth rate of 22.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 381.38M | -29.45% |
| Dec 31, 2025 | 540.61M | -41.45% |
| Dec 31, 2024 | 923.27M | 47.09% |
| Dec 29, 2023 | 627.69M | 50.94% |
| Dec 30, 2022 | 415.87M | -3.86% |
| Dec 31, 2021 | 432.55M | 69.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accretion Nutraveda | 1.31B |
| Krebs Biochemicals & Industries | 1.20B |
| Resonance Specialties | 1.13B |
| Tyche Industries | 1.10B |
| Bacil Pharma | 716.93M |
| Crestchem | 267.81M |
| Ishita Drugs and Industries | 202.14M |
| Venmax Drugs and Pharmaceuticals | 185.06M |